Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a pipeline of novel and highly differentiated antibacterial and rare disease product candidates focused on patients' unmet needs with multi-drug resistant (MDR) bacterial infections. 

Aubri Hutchins

Senior Director, Head Of Clinical Operations at Spero Therapeutics

Org chart

Teams

Offices

Related people

Nabin Kumar Timalsina

Dana Levadnuk

Andrew Ueeck

Dave Dammertz

Edward Kim